Compounds > rs 8359
Page last updated: 2024-09-05

rs 8359 and Depressive Disorder

rs 8359 has been researched along with Depressive Disorder in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plenker, A; Püchler, K; Volz, HP2

Trials

2 trial(s) available for rs 8359 and Depressive Disorder

ArticleYear
The effects of RS-8359 on cardiovascular function in healthy subjects and depressed patients.
    International clinical psychopharmacology, 1997, Volume: 12 Suppl 5

    Topics: Adult; Blood Pressure; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Electrocardiography; Hemodynamics; Humans; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Nitriles; Pyrimidines; Tyramine

1997
Safety, tolerability and efficacy of the reversible monoamine oxidase inhibitor RS-8359 in early clinical trials.
    International clinical psychopharmacology, 1997, Volume: 12 Suppl 5

    Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Nitriles; Prospective Studies; Pyrimidines

1997